Mark Baldry - Net Worth and Insider Trading

Mark Baldry Net Worth

The estimated net worth of Mark Baldry is at least $108,696 dollars as of 2026-08-13. Mark Baldry is the Chief Commercial Officer of X4 Pharmaceuticals Inc and owns about 25,337 shares of X4 Pharmaceuticals Inc (XFOR) stock worth over $108,696. Details can be seen in Mark Baldry's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Baldry has not made any transactions after 2025-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mark Baldry

To

Are these stocks worth buying? — GuruFocus analysis for each holding

Mark Baldry Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Baldry owns 3 companies in total, including Wave Life Sciences Inc (WVE) , Amicus Therapeutics Inc (FOLD) , and X4 Pharmaceuticals Inc (XFOR) .

Click here to see the complete history of Mark Baldry’s form 4 insider trades.

Insider Ownership Summary of Mark Baldry

Ticker Company Transaction Date Type of Owner
WVE Wave Life Sciences Inc 2019-08-05 Chief Commerical Officer
FOLD Amicus Therapeutics Inc 2015-06-01 VP Global Marketing
XFOR X4 Pharmaceuticals Inc 2025-05-16 Chief Commercial Officer

Mark Baldry Latest Holdings Summary

Mark Baldry currently owns a total of 1 stock. Mark Baldry owns 25,337 shares of X4 Pharmaceuticals Inc (XFOR) as of May 16, 2025, with a value of $108,696.

Latest Holdings of Mark Baldry

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
XFOR X4 Pharmaceuticals Inc 2025-05-16 25,337 4.29 108,696

Holding Weightings of Mark Baldry


Mark Baldry Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Baldry has made a total of 5 transactions in X4 Pharmaceuticals Inc (XFOR) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in X4 Pharmaceuticals Inc is the acquisition of 1,032 shares on May 16, 2025, which cost Mark Baldry around $2,559.

Insider Trading History of Mark Baldry

* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Baldry Trading Performance

GuruFocus tracks the stock performance after each of Mark Baldry's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Baldry is 11.81%. GuruFocus also compares Mark Baldry's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Baldry within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark Baldry's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark Baldry

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 29.8 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 27.64 LIMIT LIMIT LIMIT LIMIT LIMIT

Get the full picture on these stocks
See GF Score, valuation, financials, and warning signs for every stock Mark Baldry owns.
View XFOR Analysis

Mark Baldry Ownership Network

Ownership Network List of Mark Baldry

No Data

Ownership Network Relation of Mark Baldry

Insider Network Chart


Mark Baldry Owned Company Details

What does Wave Life Sciences Inc do?

Who are the key executives at Wave Life Sciences Inc?

Mark Baldry is the Chief Commerical Officer of Wave Life Sciences Inc. Other key executives at Wave Life Sciences Inc include Chief Scientific Officer Erik Ingelsson , Chief Medical Officer Christopher I Wright , and 10 percent owner Ra Capital Healthcare Fund Lp .

Wave Life Sciences Inc (WVE) Insider Trades Summary

Over the past 18 months, Mark Baldry made no insider transaction in Wave Life Sciences Inc (WVE). Other recent insider transactions involving Wave Life Sciences Inc (WVE) include a net sale of 485,483 shares made by Chris Francis , a net sale of 396,856 shares made by Paul Bolno , and a net sale of 156,345 shares made by Aik Na Tan .

In summary, during the past 3 months, insiders sold 0 shares of Wave Life Sciences Inc (WVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,572,253 shares of Wave Life Sciences Inc (WVE) were sold and 10,243,496 shares were bought by its insiders, resulting in a net purchase of 8,671,243 shares.

Wave Life Sciences Inc (WVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Wave Life Sciences Inc Insider Transactions

No Available Data

Mark Baldry Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Baldry. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Mark Baldry's mailing address is: Cranbury Nj 08512.